Merck & Co., Inc. 4

Accession 0001225208-15-016368

$MRKCIK 0000310158operating

View on SEC.gov Company Profile

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 2:41 PM ET

Size

31.7 KB

Accession

0001225208-15-016368

Insider Transaction Report

Form 4

Period: 2015-07-31

Merck & Co., Inc.MRK

Golestani Clark

EVP & Chief Info Officer

Transactions

Sale
Common Stock
2015-07-31$59.09/sh−30,065$1,776,652→ 12,163.12 total
Exercise/Conversion
Stock Option (right to buy)
2015-07-31−2,275→ 0 total
Exercise: $45.85From: 2007-11-01Exp: 2016-10-31→ Common Stock (2,275 underlying)
Sale
Common Stock
2015-07-31$58.98/sh−838$49,422→ 43,140.12 total
Exercise/Conversion
Stock Option (right to buy)
2015-07-31−3,120→ 0 total
Exercise: $44.19From: 2008-03-02Exp: 2017-03-01→ Common Stock (3,120 underlying)
Exercise/Conversion
Stock Option (right to buy)
2015-07-31−2,602→ 0 total
Exercise: $33.49From: 2011-05-07Exp: 2020-05-06→ Common Stock (2,602 underlying)
Exercise/Conversion
Common Stock
2015-07-31$36.56/sh+8,085$295,588→ 30,797.12 total
Exercise/Conversion
Common Stock
2015-07-31$44.30/sh+5,200$230,360→ 35,997.12 total
Exercise/Conversion
Common Stock
2015-07-31$44.19/sh+3,120$137,873→ 39,117.12 total
Exercise/Conversion
Common Stock
2015-07-31$33.49/sh+2,602$87,141→ 41,719.12 total
Exercise/Conversion
Common Stock
2015-07-31$45.85/sh+2,275$104,309→ 43,994.12 total
Exercise/Conversion
Stock Option (right to buy)
2015-07-31−5,200→ 0 total
Exercise: $44.30From: 2009-02-28Exp: 2018-02-28→ Common Stock (5,200 underlying)
Exercise/Conversion
Common Stock
2015-07-31$39.29/sh+14,260$560,275→ 22,712.12 total
Sale
Common Stock
2015-07-31$58.98/sh−16$944→ 43,978.12 total
Sale
Common Stock
2015-07-31$58.98/sh−912$53,787→ 42,228.12 total
Exercise/Conversion
Stock Option (right to buy)
2015-07-31−14,260→ 0 total
Exercise: $39.29From: 2013-05-02Exp: 2022-05-01→ Common Stock (14,260 underlying)
Exercise/Conversion
Stock Option (right to buy)
2015-07-31−8,085→ 0 total
Exercise: $36.56From: 2012-05-04Exp: 2021-05-03→ Common Stock (8,085 underlying)

Holdings

Common Stock - 401(k) Plan
(indirect: By 401(k))
8,951.321

Footnotes (9)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.0600 to $59.1250, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
[F2]Since the date of the reporting person's last ownership report, Mr. Golestani transferred 953 shares of common stock of Merck & Co., Inc. to his former spouse pursuant to a domestic relations order. Holding also include shares acquired in dividend reinvestment transactions.
[F3]Includes shares acquired and dividends earned through July 8, 2015, in the Merck U.S. Savings Plan, a 401(k) plan.
[F4]The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.
[F5]The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010.
[F6]The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015.
[F7]The option became exercisable in equal installments on 5/4/2012, 5/4/2013, 5/4/2014.
[F8]The option became exercisable in equal installments on 5/7/2011, 5/7/2012 and 5/7/2013.
[F9]The option became exercisable in equal installments on 11/1/2007, 11/1/2008 and 11/1/2009.

Documents

1 file

4
doc4.xmlPrimary

Issuer

Merck & Co., Inc.

CIK 0000310158

→

Entity typeoperating

IncorporatedNJ

Related Parties

filerCIK 0000310158

Filing Metadata

Form type: 4
Filed: Aug 3, 8:00 PM ET
Accepted: Aug 4, 2:41 PM ET
Size: 31.7 KB

View on SEC.gov